ASX - Delayed Quote AUD

MedAdvisor Limited (MDR.AX)

0.0940

-0.0020

(-2.08%)

At close: 4:10:48 PM GMT+10

MedAdvisor First Half 2025 Earnings: EPS: AU$0.003 (vs AU$0.013 in 1H 2024)

MedAdvisor ( ASX:MDR ) First Half 2025 Results Key Financial Results Revenue: AU$57.1m (down 24% from 1H 2024). Net...

Simply Wall St. last month

MDR.AX
-2.08%
Is It Too Late To Consider Buying MedAdvisor Limited (ASX:MDR)?

While MedAdvisor Limited ( ASX:MDR ) might not have the largest market cap around , it received a lot of attention from...

Simply Wall St. 2 months ago

MDR.AX
-2.08%
Is There An Opportunity With MedAdvisor Limited's (ASX:MDR) 48% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, MedAdvisor fair value estimate is AU$0.36 MedAdvisor is...

Simply Wall St. 3 months ago

MDR.AX
-2.08%
MedAdvisor Limited's (ASX:MDR) top owners are retail investors with 40% stake, while 38% is held by private companies

Key Insights The considerable ownership by retail investors in MedAdvisor indicates that they collectively have a...

Simply Wall St. 5 months ago

MDR.AX
-2.08%
Are MedAdvisor Limited's (ASX:MDR) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

It is hard to get excited after looking at MedAdvisor's (ASX:MDR) recent performance, when its stock has declined 31...

Simply Wall St. 6 months ago

MDR.AX
-2.08%
MedAdvisor's (ASX:MDR) investors will be pleased with their stellar 108% return over the last year

While MedAdvisor Limited ( ASX:MDR ) shareholders are probably generally happy, the stock hasn't had particularly good...

Simply Wall St. 6 months ago

MDR.AX
-2.08%
MedAdvisor Solutions Launches Pharmacy Advisory Group to Empower and Expand the Role of the Pharmacist

MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, announced today the launch of its Pharmacy Advisory Group. The collaboration of industry experts will offer key insights to help MedAdvisor deliver solutions to improve the medication journey, streamline workflow for pharmacists, and position pharmacies as a critical part of primary care delivery. Today's news builds on the company's broader strategy to successfully meet the evolving needs of the pharmacy indu

PR Newswire 7 months ago

MDR.AX
-2.08%
Private companies own 34% of MedAdvisor Limited (ASX:MDR) shares but individual investors control 36% of the company

Key Insights The considerable ownership by individual investors in MedAdvisor indicates that they collectively have a...

Simply Wall St. 10 months ago

MDR.AX
-2.08%
MedAdvisor Limited's (ASX:MDR) Path To Profitability

MedAdvisor Limited ( ASX:MDR ) is possibly approaching a major achievement in its business, so we would like to shine...

Simply Wall St. 11 months ago

MDR.AX
-2.08%

Performance Overview

Return	MDR.AX	S&P/ASX 200 [XJO] (^AXJO)
YTD	-58.22%	-0.02%
1-Year	-69.68%	+6.93%
3-Year	-55.24%	+10.77%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

MedAdvisor Limited (MDR.AX)

MedAdvisor First Half 2025 Earnings: EPS: AU$0.003 (vs AU$0.013 in 1H 2024)

Is It Too Late To Consider Buying MedAdvisor Limited (ASX:MDR)?

Is There An Opportunity With MedAdvisor Limited's (ASX:MDR) 48% Undervaluation?

MedAdvisor Limited's (ASX:MDR) top owners are retail investors with 40% stake, while 38% is held by private companies

Are MedAdvisor Limited's (ASX:MDR) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

MedAdvisor's (ASX:MDR) investors will be pleased with their stellar 108% return over the last year

MedAdvisor Solutions Launches Pharmacy Advisory Group to Empower and Expand the Role of the Pharmacist

Private companies own 34% of MedAdvisor Limited (ASX:MDR) shares but individual investors control 36% of the company

MedAdvisor Limited's (ASX:MDR) Path To Profitability

Performance Overview